Globus Medical, Inc.
GMED
$85.90
-$0.04-0.05%
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 3.14B | 3.10B | 2.94B | 2.77B | 2.63B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.14B | 3.10B | 2.94B | 2.77B | 2.63B |
| Cost of Revenue | 976.26M | 977.62M | 938.90M | 900.39M | 924.74M |
| Gross Profit | 2.17B | 2.12B | 2.00B | 1.87B | 1.70B |
| SG&A Expenses | 1.17B | 1.19B | 1.14B | 1.08B | 1.04B |
| Depreciation & Amortization | 118.29M | 118.92M | 118.19M | 118.75M | 118.98M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.42B | 2.44B | 2.34B | 2.25B | 2.22B |
| Operating Income | 729.76M | 663.43M | 599.71M | 523.38M | 403.09M |
| Income Before Tax | 660.12M | 658.47M | 605.07M | 460.50M | 373.54M |
| Income Tax Expenses | 124.69M | 71.77M | 67.20M | 36.72M | 16.89M |
| Earnings from Continuing Operations | 535.43 | 586.71 | 537.87 | 423.78 | 356.65 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 535.43M | 586.71M | 537.87M | 423.78M | 356.65M |
| EBIT | 729.76M | 663.43M | 599.71M | 523.38M | 403.09M |
| EBITDA | 1.01B | 944.08M | 876.13M | 798.03M | 673.67M |
| EPS Basic | 3.97 | 4.35 | 3.98 | 3.13 | 2.63 |
| Normalized Basic EPS | 3.44 | 3.11 | 2.81 | 2.30 | 1.77 |
| EPS Diluted | 3.90 | 4.29 | 3.93 | 3.10 | 2.60 |
| Normalized Diluted EPS | 3.39 | 3.07 | 2.78 | 2.27 | 1.74 |
| Average Basic Shares Outstanding | 539.33M | 539.48M | 540.88M | 543.19M | 544.31M |
| Average Diluted Shares Outstanding | 547.54M | 546.66M | 548.24M | 551.38M | 554.05M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |